0001571049-15-010022.txt : 20151216 0001571049-15-010022.hdr.sgml : 20151216 20151216210054 ACCESSION NUMBER: 0001571049-15-010022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151214 FILED AS OF DATE: 20151216 DATE AS OF CHANGE: 20151216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP CENTRAL INDEX KEY: 0001069899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 131840497 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-329-7300 MAIL ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC DATE OF NAME CHANGE: 19980908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Miller Larry Lee CENTRAL INDEX KEY: 0001603584 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36410 FILM NUMBER: 151292154 MAIL ADDRESS: STREET 1: 8 HAZELWOOD COURT CITY: WARREN STATE: NJ ZIP: 07059 FORMER NAME: FORMER CONFORMED NAME: Miller Larry Lars DATE OF NAME CHANGE: 20140325 4 1 t1502959_miller-f4.xml OWNERSHIP DOCUMENT X0306 4 2015-12-14 0 0001069899 PHIBRO ANIMAL HEALTH CORP PAHC 0001603584 Miller Larry Lee 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666-6712 0 1 0 0 President, Animal Health Class A Common Stock 2015-12-14 4 M 0 23910 11.83 A 23910 D Class A Common Stock 2015-12-14 4 S 0 23910 30.74 D 0 D Class A Common Stock 2015-12-15 4 M 0 36090 11.83 A 36090 D Class A Common Stock 2015-12-15 4 S 0 36090 31.00 D 0 D Option to purchase Class A Common Stock 11.83 2015-12-14 4 M 0 23910 0 D 2012-03-01 2019-02-28 Class A Common Stock 23910 528590 D Option to purchase Class A Common Stock 11.83 2015-12-15 4 M 0 36090 0 D 2012-03-01 2019-02-28 Class A Common Stock 36090 492500 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2015. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.28 to $31.28, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.61 to $31.29, inclusive. This amount reflects the aggregate number of options to purchase Class A Common Stock with an expiration date of February 28, 2019 beneficially owned by the Reporting Person. Previously, the Reporting Person reported such options on different rows of Table II based on the applicable Exercisable Date. /s/ Thomas G. Dagger, as Attorney-in-Fact for Larry L. Miller 2015-12-16